Apellis Pharmaceuticals

-$1.57 (-2.96%) As of 7:36 PM UTC today

Why Robinhood?

You can buy or sell APLS and other stocks, options, and ETFs commission-free!

About APLS

Apellis Pharmaceuticals, Inc. Common Stock, also called Apellis Pharmaceuticals, is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds.

CEO
Cedric Francois
Employees
374
Headquarters
Waltham, Massachusetts
Founded
2009

APLS Key Statistics

Market Cap
4.27B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.32M
High Today
$55.00
Low Today
$51.18
Open Price
$53.83
Volume
961.90K
52 Week High
$58.47
52 Week Low
$25.49

APLS Earnings

-$2.32
-$1.24
-$0.15
$0.93
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 29, After Hours

You May Also Like

STRA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure